Search Results

There are 22467 results for: content related to: Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long-term followup study of thirty-two patients

  1. You have free access to this content
    Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long-term followup study

    Arthritis & Rheumatism

    Volume 54, Issue 11, November 2006, Pages: 3696–3706, David Saadoun, Mathieu Resche-Rigon, Vincent Thibault, Jean-Charles Piette and Patrice Cacoub

    Version of Record online : 30 OCT 2006, DOI: 10.1002/art.22168

  2. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  3. You have free access to this content
    A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitis

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 835–842, Michael C. Sneller, Zonghui Hu and Carol A. Langford

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.34322

  4. You have free access to this content
    Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection

    Intervention Review

    The Cochrane Library

    Tim J Benstead, Colin H Chalk and Natalie E Parks

    Published Online : 20 DEC 2014, DOI: 10.1002/14651858.CD010404.pub2

  5. You have free access to this content
    Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

    Arthritis & Rheumatism

    Volume 64, Issue 4, April 2012, Pages: 1215–1226, Brad H. Rovin, Richard Furie, Kevin Latinis, R. John Looney, Fernando C. Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P. Garg, Paul Brunetta, Gerald Appel and LUNAR Investigator Group

    Version of Record online : 27 MAR 2012, DOI: 10.1002/art.34359

  6. You have free access to this content
    Repeated courses of rituximab in chronic ITP: Three different regimens

    American Journal of Hematology

    Volume 84, Issue 10, October 2009, Pages: 661–665, Aisha Hasan, Marc Michel, Vivek Patel, Roberto Stasi, Susanna Cunningham-Rundles, John P. Leonard and James Bussel

    Version of Record online : 25 JUL 2009, DOI: 10.1002/ajh.21512

  7. You have free access to this content
    Research Poster Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A362–A659,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_2.x

  8. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  9. You have free access to this content
    Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  10. You have free access to this content
    Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

    American Journal of Transplantation

    Volume 10, Issue 1, January 2010, Pages: 89–98, N. Kamar, O. Milioto, B. Puissant-Lubrano, L. Esposito, M. C. Pierre, A. Ould Mohamed, L. Lavayssière, O. Cointault, D. Ribes, I. Cardeau, M. B. Nogier, D. Durand, M. Abbal, A. Blancher and L. Rostaing

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1600-6143.2009.02785.x

  11. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  12. You have free access to this content
    Rituximab in the treatment of autoimmune haemolytic anaemia

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 709–719, Chaturaka Rodrigo, Senaka Rajapakse and Lallindra Gooneratne

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12498

  13. You have free access to this content
    Research Podium Abstracts

    Value in Health

    Volume 11, Issue 6, November 2008, Pages: A335–A362,

    Version of Record online : 14 OCT 2008, DOI: 10.1111/j.1524-4733.2008.00453_1.x

  14. You have free access to this content
    Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease

    British Journal of Clinical Pharmacology

    Volume 76, Issue 5, November 2013, Pages: 734–740, Florent Puisset, Mélanie White-Koning, Nassim Kamar, Antoine Huart, Frédérique Haberer, Hélène Blasco, Chantal Le Guellec, Thierry Lafont, Anaïs Grand, Lionel Rostaing, Etienne Chatelut and Jacques Pourrat

    Version of Record online : 21 OCT 2013, DOI: 10.1111/bcp.12098

  15. You have free access to this content
    Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone

    Cancer

    Volume 107, Issue 1, 1 July 2006, Pages: 125–135, Apostolia M. Tsimberidou, Daniel Catovsky, Ellen Schlette, Susan O'Brien, William G. Wierda, Hagop Kantarjian, Guillermo Garcia-Manero, Sijin Wen, Kim-Anh Do, Susan Lerner and Michael J. Keating

    Version of Record online : 12 MAY 2006, DOI: 10.1002/cncr.21931

  16. You have free access to this content
    Biologic agents in the treatment of glomerulonephritides

    Nephrology

    Volume 20, Issue 11, November 2015, Pages: 767–787, See Cheng Yeo and Adrian Liew

    Version of Record online : 7 OCT 2015, DOI: 10.1111/nep.12530

  17. You have free access to this content
    Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 622–632, Maria W. Greenwald, William J. Shergy, Jeffrey L. Kaine, Marianne T. Sweetser, Kye Gilder and Matthew D. Linnik

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30194

  18. Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

    Intervention Review

    The Cochrane Library

    Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert and Nicole Skoetz

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD008079.pub2

  19. Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1918–1926, Jing Li, Jianguo Zhi, Michael Wenger, Nancy Valente, Anna Dmoszynska, Tadeusz Robak, Ranvir Mangat, Amita Joshi and Jennifer Visich

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011430506

  20. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735